Cost-effectiveness of point-of-care C-reactive protein testing to inform antibiotic prescribing decisions by Raymond Oppong, Mark Jit, Richard D Smith, Christopher C Butler, Hasse Melbye, Sigvard Mölstad, and Joanna Coast BJGP Volume 63(612):e465-e471 July 1, 2013 ©2013 by British Journal of General Practice
Incremental net benefits (INB) of CRP versus no CRP (95% CI). Raymond Oppong et al. Br J Gen Pract 2013;63:e465-e471 ©2013 by British Journal of General Practice
Cost-effectiveness acceptability curve. Cost-effectiveness acceptability curve. CRP = C-reactive protein. Raymond Oppong et al. Br J Gen Pract 2013;63:e465-e471 ©2013 by British Journal of General Practice